Vericel Corp. (VCEL)
40.96
-0.22
(-0.53%)
USD |
NASDAQ |
Aug 28, 16:00
40.93
-0.03
(-0.07%)
After-Hours: 20:00
Vericel Free Cash Flow : 61.66M for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 61.66M |
| March 31, 2026 | 47.49M |
| December 31, 2025 | 24.75M |
| September 30, 2025 | 20.38M |
| June 30, 2025 | -8.301M |
| March 31, 2025 | -6.608M |
| December 31, 2024 | -5.811M |
| September 30, 2024 | -12.02M |
| June 30, 2024 | -2.19M |
| March 31, 2024 | 2.036M |
| December 31, 2023 | 7.798M |
| September 30, 2023 | 11.40M |
| June 30, 2023 | 12.41M |
| March 31, 2023 | 7.575M |
| December 31, 2022 | 9.015M |
| September 30, 2022 | 12.72M |
| June 30, 2022 | 12.28M |
| March 31, 2022 | 13.77M |
| December 31, 2021 | 21.12M |
| September 30, 2021 | 21.83M |
| June 30, 2021 | 24.86M |
| March 31, 2021 | 18.72M |
| December 31, 2020 | 14.95M |
| September 30, 2020 | 7.468M |
| June 30, 2020 | 10.13M |
| Date | Value |
|---|---|
| March 31, 2020 | -5.752M |
| December 31, 2019 | -9.799M |
| September 30, 2019 | -10.55M |
| June 30, 2019 | -16.52M |
| March 31, 2019 | -3.389M |
| December 31, 2018 | -3.09M |
| September 30, 2018 | -5.008M |
| June 30, 2018 | -11.66M |
| March 31, 2018 | -11.28M |
| December 31, 2017 | -14.69M |
| September 30, 2017 | -24.22M |
| June 30, 2017 | -22.88M |
| March 31, 2017 | -23.22M |
| December 31, 2016 | -21.31M |
| September 30, 2016 | -16.03M |
| June 30, 2016 | -13.10M |
| March 31, 2016 | -12.59M |
| December 31, 2015 | -15.77M |
| September 30, 2015 | -18.63M |
| June 30, 2015 | -25.63M |
| March 31, 2015 | -26.03M |
| December 31, 2014 | -26.24M |
| September 30, 2014 | -23.59M |
| June 30, 2014 | -19.24M |
| March 31, 2014 | -17.88M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| AbbVie, Inc. | 18.21B |
| ADMA Biologics, Inc. | 116.22M |
| Kyntra Bio, Inc. | -38.06M |
| Conexeu Sciences, Inc. | -- |
| ACADIA Pharmaceuticals, Inc. | 145.62M |